HEALTH TIPS.: Three F.D.A. Advisers Resign Over Agency’s Approval of Alzheimer’s Drug: The drug, Aduhelm, a monthly infusion priced at $56,000 per year, was approved this week despite weak evidence that it helps patients

Friday, 11 June 2021

Three F.D.A. Advisers Resign Over Agency’s Approval of Alzheimer’s Drug: The drug, Aduhelm, a monthly infusion priced at $56,000 per year, was approved this week despite weak evidence that it helps patients

Three F.D.A. Advisers Resign Over Agency’s Approval of Alzheimer’s Drug: The drug, Aduhelm, a monthly infusion priced at $56,000 per year, was approved this week despite weak evidence that it helps patients

submitted by /u/DoremusJessup
[link] [comments]

from Health https://ift.tt/3xccg4s
via IFTTT

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)